Australian biotech market today 03.04.09
Friday, 03 April, 2009
A very flat day’s trading on the ASX saw biotech and pharma go against the grain at the close of trade today, with a slight drop in indices as opposed to overall gains.
Starpharma (ASX:SPL) has called a trading halt until an announcement on Tuesday.
Atcor (ASX:ACG) is down 1c, which still means a 7 per cent drop in value, while Acrux (ASX:ACR) is up 3c, or 5.6 per cent.
Bionomics (ASX:BNO) is down a touch, as is Biota (ASX:BTA).
Circadian Technologies (ASX:CIR) is up 3c, as is CathRx (ASX:CXD), while Clinuvel (ASX:CUV) is up two.
With the Big Three, Cochlear (ASX:COH) has dropped below $50 while CSL (ASX:CSL) is down $1 on high volumes. ResMed (ASX:RMD) is down a touch, too.
Mesoblast (ASX:MSB) is down on a change in substantial shareholding and Pharmaxis (ASX:PXS) is still riding the wave of recent good interim data, up to $1.88.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
